The Impact of the CB2 Cannabinoid Receptor in Inflammatory Diseases: An Update

被引:0
|
作者
Rakotoarivelo, Volatiana [1 ,2 ]
Mayer, Thomas Z. [1 ,2 ,3 ,4 ]
Simard, Melissa [1 ,2 ]
Flamand, Nicolas [1 ,2 ]
Di Marzo, Vincenzo [1 ,2 ,3 ,4 ,5 ]
机构
[1] Univ Laval, Ctr Rech Inst, Dept Med, Univ Cardiol & Pneumol Quebec, Quebec City, PQ G1V 4G5, Canada
[2] Univ Laval, Canada Excellence Res Chair Microbiome Endocannabi, Quebec City, PQ G1V 0V6, Canada
[3] Univ Laval, Ecole Nutr, Inst Nutr & Aliments Fonct, Quebec City, PQ G1V 0V6, Canada
[4] Univ Laval, Ecole Nutr, Ctr NUTRISS, Quebec City, PQ G1V 0V6, Canada
[5] Joint Int Unit CNR Italy & Univ Laval, Chem & Biomol Res Microbiome & Its Impact Metab H, Quebec City, PQ G1V 0V6, Canada
来源
MOLECULES | 2024年 / 29卷 / 14期
基金
加拿大健康研究院;
关键词
inflammatory diseases; inflammation; cannabinoid; endocannabinoid; cannabinoid receptor; ACID AMIDE HYDROLASE; ENDOGENOUS LIGAND 2-ARACHIDONOYLGLYCEROL; MONOGLYCERIDE LIPASE DEFICIENCY; INNATE LYMPHOID-CELLS; FATTY LIVER-DISEASE; TYPE-2; RECEPTOR; MURINE MODEL; ENDOCANNABINOID SYSTEM; EXPERIMENTAL COLITIS; NOLADIN ETHER;
D O I
10.3390/molecules29143381
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The emergence of inflammatory diseases is a heavy burden on modern societies. Cannabis has been used for several millennia to treat inflammatory disorders such as rheumatism or gout. Since the characterization of cannabinoid receptors, CB1 and CB2, the potential of cannabinoid pharmacotherapy in inflammatory conditions has received great interest. Several studies have identified the importance of these receptors in immune cell migration and in the production of inflammatory mediators. As the presence of the CB2 receptor was documented to be more predominant in immune cells, several pharmacological agonists and antagonists have been designed to treat inflammation. To better define the potential of the CB2 receptor, three online databases, PubMed, Google Scholar and clinicaltrial.gov, were searched without language restriction. The full texts of articles presenting data on the endocannabinoid system, the CB2 receptor and its role in modulating inflammation in vitro, in animal models and in the context of clinical trials were reviewed. Finally, we discuss the clinical potential of the latest cannabinoid-based therapies in inflammatory diseases.
引用
收藏
页数:36
相关论文
共 50 条
  • [1] Cannabinoid receptor 2 (CB2) agonists and antagonists: a patent update
    Morales, Paula
    Hernandez-Folgado, Laura
    Goya, Pilar
    Jagerovic, Nadine
    [J]. EXPERT OPINION ON THERAPEUTIC PATENTS, 2016, 26 (07) : 843 - 856
  • [2] Cannabinoid Receptor CB2 Structure and CB2/Gi Signaling Mechanisms
    Xing, Changrui
    Zhang, Cheng
    Xie, Xiang-Qun
    [J]. FASEB JOURNAL, 2019, 33
  • [3] CB2: a cannabinoid receptor with an identity crisis
    Atwood, Brady K.
    Mackie, Ken
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2010, 160 (03) : 467 - 479
  • [4] Brain Cannabinoid CB2 Receptor in Schizophrenia
    Ishiguro, Hiroki
    Horiuchi, Yasue
    Ishikawa, Maya
    Koga, Minori
    Imai, Keiko
    Suzuki, Yoshimi
    Morikawa, Miyuki
    Inada, Toshiya
    Watanabe, Yuichiro
    Takahashi, Makoto
    Someya, Toshiyuki
    Ujike, Hiroshi
    Iwata, Nakao
    Ozaki, Norio
    Onaivi, Emmanuel S.
    Kunugi, Hiroshi
    Sasaki, Tsukasa
    Itokawa, Masanari
    Arai, Makoto
    Niizato, Kazuhiro
    Iritani, Shyuji
    Naka, Izumi
    Ohashi, Jun
    Kakita, Akiyoshi
    Takahashi, Hitoshi
    Nawa, Hiroyuki
    Arinami, Tadao
    [J]. BIOLOGICAL PSYCHIATRY, 2010, 67 (10) : 974 - 982
  • [5] CB2 cannabinoid receptor mediation of antinociception
    Ibrahim, Mohab M.
    Rude, Megan L.
    Stagg, Nicola J.
    Mata, Heriberto P.
    Lai, Josephine
    Vanderah, Todd W.
    Porreca, Frank
    Buckley, Nancy E.
    Makriyannis, Alexandros
    Malan, T. Philip, Jr.
    [J]. PAIN, 2006, 122 (1-2) : 36 - 42
  • [6] Targeting the CB2 cannabinoid receptor in osteoporosis
    Bab, Itai
    Ofek, Orr
    [J]. EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2011, 6 (02) : 135 - 138
  • [7] Cannabichromene is a cannabinoid CB2 receptor agonist
    Udoh, Michael
    Santiago, Marina
    Devenish, Steven
    McGregor, Iain S.
    Connor, Mark
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2019, 176 (23) : 4537 - 4547
  • [8] Modulation of the cannabinoid CB2 receptor in microglial cells in response to inflammatory stimuli
    Maresz, K
    Carrier, EJ
    Ponomarev, ED
    Hillard, CJ
    Dittel, BN
    [J]. JOURNAL OF NEUROCHEMISTRY, 2005, 95 (02) : 437 - 445
  • [9] Pleiotropic effects of the CB2 cannabinoid receptor activation on human monocyte migration:: implications for atherosclerosis and inflammatory diseases
    Pacher, Pal
    Ungvari, Zoltan
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2008, 294 (03): : H1133 - H1134
  • [10] Targeting the cannabinoid CB2 receptor: modelling and structural determinants of CB2 selective ligands
    Poso, A.
    Huffman, J. W.
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2008, 153 (02) : 335 - 346